These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24174662)

  • 1. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
    Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
    J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.
    Sun MY; Izumi Y; Benz A; Zorumski CF; Mennerick S
    J Neurophysiol; 2016 Mar; 115(3):1263-72. PubMed ID: 26745248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cholesterol Metabolic Enzyme CYP46A1 and Its Metabolite 24S-Hydroxycholesterol in Ischemic Stroke.
    Sun H; Yang T; Simon RP; Xiong ZG; Leng T
    Stroke; 2024 Oct; 55(10):2492-2501. PubMed ID: 39224978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols Modulate the Acute Effects of Ethanol on Hippocampal
    Izumi Y; Mennerick SJ; Doherty JJ; Zorumski CF
    J Pharmacol Exp Ther; 2021 Apr; 377(1):181-188. PubMed ID: 33441369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation.
    Sun MY; Taylor A; Zorumski CF; Mennerick S
    PLoS One; 2017; 12(3):e0174416. PubMed ID: 28346482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.
    Linsenbardt AJ; Taylor A; Emnett CM; Doherty JJ; Krishnan K; Covey DF; Paul SM; Zorumski CF; Mennerick S
    Neuropharmacology; 2014 Oct; 85():232-42. PubMed ID: 24878244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
    Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.
    Sun MY; Linsenbardt AJ; Emnett CM; Eisenman LN; Izumi Y; Zorumski CF; Mennerick S
    Neuroscientist; 2016 Apr; 22(2):132-44. PubMed ID: 25628343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
    Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
    Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors.
    Izumi Y; Auberson YP; Zorumski CF
    J Neurosci; 2006 Jul; 26(27):7181-8. PubMed ID: 16822975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors.
    Beckley JT; Aman TK; Ackley MA; Kazdoba TM; Lewis MC; Smith AC; Farley BJ; Dai J; Deats W; Hoffmann E; Robichaud AJ; Doherty JJ; Quirk MC
    Br J Pharmacol; 2024 Apr; 181(7):1028-1050. PubMed ID: 37698384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloprotease 3 Activity Supports Hippocampal EPSP-to-Spike Plasticity Following Patterned Neuronal Activity via the Regulation of NMDAR Function and Calcium Flux.
    Brzdąk P; Włodarczyk J; Mozrzymas JW; Wójtowicz T
    Mol Neurobiol; 2017 Jan; 54(1):804-816. PubMed ID: 27351676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.
    Radosevic M; Planagumà J; Mannara F; Mellado A; Aguilar E; Sabater L; Landa J; García-Serra A; Maudes E; Gasull X; Lewis M; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34903638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zelquistinel acts at an extracellular binding domain to modulate intracellular calcium inactivation of N-methyl-d-aspartate receptors.
    Zhang XL; Li YX; Berglund N; Burgdorf JS; Donello JE; Moskal JR; Stanton PK
    Neuropharmacology; 2024 Nov; 259():110100. PubMed ID: 39117105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.
    Wei X; Nishi T; Kondou S; Kimura H; Mody I
    Neuropharmacology; 2019 Apr; 148():11-20. PubMed ID: 30594698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
    Mony L; Kew JN; Gunthorpe MJ; Paoletti P
    Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.